Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Tue, 17th Mar 2020 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES PEARSON TO 'NEUTRAL' ('SELL') - PRICE TARGET 605 (505) PENCE

----------

GOLDMAN RAISES INFORMA TO 'NEUTRAL' ('SELL') - PRICE TARGET 729 (744) PENCE

----------

GOLDMAN CUTS RELX PRICE TARGET TO 2185.0 (2302.8) PENCE - 'BUY'

----------

GOLDMAN CUTS AUTO TRADER PRICE TARGET TO 653 (688) PENCE - 'BUY'

----------

GOLDMAN CUTS ITV PRICE TARGET TO 122 (147) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS WPP PRICE TARGET TO 900 (1045) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERGUSON PRICE TARGET TO 7100 (8100) PENCE - 'OVERWEIGHT'

----------

RBC CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 155 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LLOYDS BANKING PRICE TARGET TO 47 (66) PENCE - 'OUTPERFORM'

----------

RBC CUTS HSBC PRICE TARGET TO 440 (520) PENCE - 'UNDERPERFORM'

----------

RBC CUTS BARCLAYS PRICE TARGET TO 120 (170) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES STANDARD CHARTERED TO 'HOLD' ('REDUCE') - TARGET 480 (590) PENCE

----------

HSBC CUTS WPP PRICE TARGET TO 620 (1030) PENCE - 'HOLD'

----------

JPMORGAN CUTS DIAGEO PRICE TARGET TO 2150 (2800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COCA-COLA HBC PRICE TARGET TO 1980 (3000) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1550) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 8000 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6500 (7700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES UNILEVER TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 3850 (4210) PENCE

----------

JPMORGAN CUTS WHITBREAD PRICE TARGET TO 2990 (3800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS INTERCONTINENTAL HOTELS TARGET TO 4150 (4600) P - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1920 (2040) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES JUST EAT TAKEAWAY.COM TO 'BUY' ('HOLD') - PRICE TARGET 8000 PENCE

----------

FTSE 250

----------

GOLDMAN CUTS ASCENTIAL TO 'BUY' ('CONVICTION BUY') - PRICE TARGET 373 (569) PENCE

----------

KEPLER CHEUVREUX RAISES TATE & LYLE TO 'BUY' ('HOLD') - TARGET 720 PENCE

----------

LIBERUM CUTS BALFOUR BEATTY PRICE TARGET TO 320 (400) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 265 (275) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS HAMMERSON PRICE TARGET TO 200 (300) PENCE - 'BUY'

----------

HSBC CUTS 4IMPRINT GROUP PRICE TARGET TO 2215 (2820) PENCE - 'HOLD'

----------

JPMORGAN CUTS BRITVIC PRICE TARGET TO 875 (1065) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS HUNTING PRICE TARGET TO 160 (398) PENCE - 'SELL'

----------

GOLDMAN CUTS JOHN WOOD PRICE TARGET TO 282 (467) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES PETROFAC TO 'BUY' ('NEUTRAL') - TARGET 316 (433) PENCE

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 730 (790) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 270 (375) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN CUTS DAILY MAIL & GENERAL TRUST PRICE TARGET TO 632 (706) PENCE - 'SELL'

----------

LIBERUM CUTS KIER GROUP PRICE TARGET TO 115 (150) PENCE - 'BUY'

----------

BERENBERG CUTS BREEDON PRICE TARGET TO 105 (110) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.